InsidersTradesSigma
Track the Destiny Pharma plc share price and the full directors' dealings record of the company, a listed equity based in United Kingdom. Shares are listed on the UK market, under the authority of RNS (LSE). Market capitalisation: €565k. The latest transaction was disclosed on 5 August 2024 (Purchase). Among the most active insiders: Chris Tovey. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Destiny Pharma plc is a UK-based biopharmaceutical company focused on developing treatments for bacterial infections. It aims to provide innovative solutions to combat antibiotic resistance.